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Aims Treatment of arrhythmias evoked by hypothermia/rewarming remains challenging, and the underlying mechanisms
are unclear. This in vitro experimental study assessed cardiac electrophysiology in isolated rabbit hearts at tempera-
tures occurring in therapeutic and accidental hypothermia.
....................................................................................................................................................................................................
Methods
and results
Detailed ECG, surface electrogram, and panoramic optical mapping were performed in isolated rabbit hearts cooled
to moderate (31C) and severe (17C) hypothermia. Ventricular activation was unchanged at 31C while action
potential duration (APD) was significantly prolonged (176.9 ± 4.2 ms vs. 241.0 ± 2.9 ms, P < 0.05), as was ventricular
repolarization. At 17C, there were proportionally similar delays in both activation and repolarization. These
changes were reflected in the QRS and QT intervals of ECG recordings. Ventricular fibrillation threshold was signif-
icantly reduced at 31C (16.3 ± 3.1 vs. 35 ± 3.5 mA, P < 0.05) but increased at 17C (64.2 ± 9.9, P < 0.05). At 31C,
transverse conduction was relatively unchanged by cooling compared to longitudinal conduction, but at 17C both
transverse and longitudinal conduction were proportionately reduced to a similar extent. The gap junction uncou-
pler heptanol had a larger relative effect on transverse than longitudinal conduction and was able to restore the
transverse/longitudinal conduction ratio, returning ventricular fibrillation threshold to baseline values (16.3 ± 3.1 vs.
36.3 ± 4.3 mA, P < 0.05) at 31C. Rewarming to 37C restored the majority of the electrophysiological parameters.
....................................................................................................................................................................................................
Conclusions Moderate hypothermia does not significantly change ventricular conduction time but prolongs repolarization and is
pro-arrhythmic. Further cooling to severe hypothermia causes parallel changes in ventricular activation and repolar-
ization, changes which are anti-arrhythmic. Therefore, relative changes in QRS and QT intervals (QR/QTc) emerge
as an ECG-biomarker of pro-arrhythmic activity. Risk for ventricular fibrillation appears to be linked to the rela-
tively low temperature sensitivity of ventricular transmural conduction, a conclusion supported by the anti-
arrhythmic effect of heptanol at 31C.
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1. Introduction
Ventricular arrhythmias and cardiac arrest contribute to the high mortal-
ity rates observed in accidental hypothermia patients, reported between
29%1 and 80%.2 However, several case reports demonstrate successful
resuscitation after hours of cardiac arrest and core temperatures below
20C.3 This neuroprotective effect of hypothermia is utilized during aor-
tic arch surgery, using temperatures down to 15C.4 Hypothermia has
also been applied therapeutically in comatose survivors of cardiac arrest,
where temperatures above 30C are considered safe.5 Although survival
is possible after extreme accidental exposure, treatment of arrhythmias
during rewarming is still challenging. Current guidelines provide only gen-
eral suggestions for pharmacologic treatment,6 which is based solely on
pre-clinical studies.7 In order to develop targeted anti-arrhythmic strate-
gies in this specific situation, we need to understand the basis for pro-
arrhythmia during cooling and rewarming.
In humans, hypothermia-induced arrhythmias commonly appear at
core temperatures below 28C, including atrial fibrillation, atrioventricu-
lar block, and ventricular fibrillation (VF).7 The pathophysiology behind
development of VF in hypothermic hearts remains unknown. Recent
findings from canine wedge preparations have shown conduction block
and re-entrant VF during rewarming, associated with transmural8 and
epicardial9 dispersion of repolarization. Combined with slowed conduc-
tion velocity (CV) at 30C in rabbit hearts,10 these circumstances may fa-
vour unidirectional block and induction of VT/VF. Optical mapping of
rabbit hearts cooled to 17C has also shown spatial alterations in CV, a
known predictor of VF.11 However, it is unclear from previous studies
whether electrophysiological changes and arrhythmic risk is directly pro-
portional to the degree of hypothermia. In the current study, whole
heart electrophysiology was examined in rabbit hearts using a series of
techniques, including panoramic optical mapping. Measurements were
carried out following gradual cooling and rewarming to temperatures
occurring in therapeutic and accidental hypothermia.
2. Materials and methods
2.1 Animal model
All experiments were undertaken in accordance with the United
Kingdom Animals (Scientific Procedures) Act of 1986 and conform to
Graphical Abstract
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the Guide for the Care and Use of Laboratory Animals published by the
National Institutes of Health (NIH Publication No. 85–23, revised 1996).
New Zealand White rabbits (n = 36) were sacrificed with an intravenous
injection of 0.5 mL/kg sodium pentobarbital (200 mg/mL, Euthatal,
Rhone, Merieux) mixed with 500 IU of heparin. Hearts were rapidly ex-
cised before being put in cold, oxygenated Tyrode’s solution, and con-
nected to a Langendorff system. They were retrogradely perfused at a
constant flow of 30 mL/min with Tyrode’s solution, gassed with 95%
O2–5% CO2, and maintained at pH 7.4. Coronary artery perfusion pres-
sure was constantly monitored via a transducer in the perfusion system.
To suppress motion artefacts, the electromechanical uncoupler blebbis-
tatin (10mM) was added to the solution.
2.2 Hypothermia and rewarming protocol
The temperatures used in this study were typical for moderate (31C)
and severe (17C) hypothermia.11 In victims of accidental hypothermia,
core temperatures well below 17C have been reported in rewarmed
patients with a good neurological outcome.12 Perfusion rate of hearts
was constant (30 mL/min) as coronary blood flow is preserved or in-
creased during hypothermia.7 Temperature was adjusted by running
Tyrode’s solution through a water-coupled heat exchanger. Gradual
cooling and rewarming was carried out in order to mimic whole body
cooling and avoid rapid cooling contracture.13 Both cooling and rewarm-
ing were paused for 5 min at 31C and 17C to stabilize hearts for
recordings. Normothermic (37C) control hearts underwent a time-
matched protocol. Hearts underwent both right atrial (RA) and right
ventricular (RV) pacing at cycle lengths of 300 ms at 37C, 450 ms at
31C, and 1700 ms at 17C, based on intrinsic rates.
2.3 Whole heart conduction times (n¼ 6)
A small section of the right atrium was removed and the anatomical re-
gion of the AV node (AVN) identified. A quadripolar electrode catheter
was placed across the tricuspid valve adjacent to the AVN. The proximal
poles recorded atrial and ventricular activation times at the AVN-level
and the distal poles recorded activation in the RV apical endocardium.
Additional electrodes were placed in the endocardium of the left ventri-
cle (LV) free wall. Pacing was allowed by platinum hook electrodes
placed in the RA and on the epicardial surface of the LV.
2.4 Measurement of ventricular fibrillation
threshold (n¼ 7)
Stable experimental settings clearly differ from the clinic and spontane-
ous occurrence of arrhythmias has low probability. Ventricular fibrilla-
tion (VF) threshold was therefore estimated as a test of pro-arrhythmic
state, using RV endocardial electrodes. At each temperature, a train of
100 constant current pulses of 4 ms duration, 10 ms apart was delivered.
The train spanned the repolarization period at all experimental tempera-
tures. Current strength was increased in steps of 5 mA until VF was sus-
tained for a period longer than 4 s. Between measurements, hearts
recovered for 1 min in normal sinus rhythm. At each temperature,
thresholds were averaged over three measurements according to Cha
et al.14
2.5 Panoramic optical mapping
Hypothermic (n = 8) and normothermic (n = 6) optical action potential
(OAP) characteristics were compared. Hearts were suspended in a
solution-filled chamber and perfused via a rotatable centrepiece con-
nected to the aortic cannula. This allowed panoramic measurements by
turning hearts to three different views at each measurement. To ensure
that changes observed during the temperature protocol were not tem-
poral, we included a normothermic control group, which remained sta-
ble through the rotation sequence and throughout a time-matched
normothermic protocol (Supplementary material online, Figure S3).
Hearts were stained with voltage sensitive dye, Di-4-ANEPPS (100mL of
1 mg/mL). Pacing was achieved through platinum hook electrodes in the
RA and RV. Hearts were illuminated with an annular array of LEDs
(OptoLED, Cairn Research Ltd.) with wavelength 480 nm. Emitted
fluorescence was collected, filtered with a long pass filter 665 nm, and fo-
cussed on a CCD chip (RedshirtImaging, Decateur, GA) acquiring images
at 1 kHz. Hearts were rotated through fixed angles (±120 from a cen-
tral position) acquiring data sequentially from three viewpoints, which
where correlated by synchronizing each image sequence with respect to
a common pacing site. A volume-conducted ECG was recorded simulta-
neously. Activation time (TAct90) was determined as time from stimulus
to 90% of the OAP upstroke; while repolarization time (TRepol90) was
time to 90% repolarization. The interval between 10% and 90% of the
OAP upstroke (TRise) was also determined. Action potential duration
(APD90) was calculated as the interval between activation and repolari-
zation time.
2.6 Conduction velocity (n¼ 9)
Conduction velocity (CV) was measured using optical mapping, during
right atrial pacing, giving total cardiac conduction (CVTot) and during ven-
tricular, epicardial pacing (CVEpi). We also measured CV using a custom-
built bipolar electrode array. Epicardial fibre orientation is such that the
long axis of the cell runs 90 from this angle to the vertical axis. Once
the fastest conduction time in the long axis was identified and longitudi-
nal conduction velocity (CVl) recorded, the electrodes were rotated 90
to record the transverse conduction (CVt). Such is the arrangement of
fibres within the myocardium this is indicative of endocardial to epicar-
dial (transmural) conduction. Both longitudinal and transverse conduc-
tion were recorded during hypothermia and rewarming.
2.7 Statistical analysis
Data are expressed as mean ± SEM. Conduction time, VF threshold, op-
tical imaging, ECG, and conduction velocity measurements were
assessed by one-way ANOVA for repeated measures. Where data were
not normally distributed, a non-parametric repeated measures analysis
of variance on ranks was used. When the ANOVA showed significant
differences, post hoc tests were performed using Tukey’s test. Data in the
Supplementary material online, Table were compared using Student’s
t-test. Differences were considered statistically significant at P < 0.05.
2.8 Computational modelling
In silico analysis was performed to assess the respective effects of individ-
ual changes in myoplasmic conductivity (riÞ and gap junction resistance
(rgj) due to hypothermia upon conduction in the longitudinal and trans-
verse directions. Specific mathematical relationships between intracellu-
lar longitudinal and transverse conductivity and extracellular longitudinal
and transverse conductivity as functions of ri and rgj were taken directly
from.15 These conductivities, computed as values of ri and rgj, were var-
ied and used directly within a bidomain representation of electrical acti-
vation within a cardiac fibre. Propagation down the myofibre was
simulated for different values of conductivity and conduction velocities
computed.
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..3. Results
3.1 Electrocardiogram
On cooling to 31C, the PR interval increased to 130% of normothermic
baseline levels (73.3± 10.8 vs. 97.8 ± 13.7 ms, P < 0.05), while intrinsic
rate decreased from 124± 10 to 75 ± 5 beats per minute (P < 0.05). The
QT interval increased to 150% (178.8± 21.4 vs. 267.9± 32.6 ms,
P < 0.05). Changes in the QRS and QR intervals were absent, QR interval
was on average 99% of normothermic baseline values. During cooling to
17C, both the QR and QT time were prolonged (25.5 ± 4.1 vs.
53.8± 9.3 ms, P < 0.05) (178.8± 21.4 vs. 591.8 ± 74.7 ms, P < 0.05) and
intrinsic rate decreased to 21± 3 beats per minute (P < 0.05). During
rewarming to 31C, the QR interval returned to baseline values, but the
QT time was still prolonged (178.8± 21.4 vs. 294.1 ± 35.5 ms, P < 0.05).
After rewarming to 37C, both parameters returned to baseline values.
J-waves were detected in two of eight hearts during hypothermia
(Figure 1).
3.2 Whole heart conduction times
During cooling to 31C, no difference in activation times from stimulus
to either atrial (stim-A) or ventricular activation (stim-V) occurred.
During cooling to 17C, all times were significantly prolonged compared
to baseline and 31C. In particular, stim-A was 462% of baseline
(76.9± 4.5 vs. 17.5 ± 1.2 ms, P < 0.01), compared to stim-V which was
280% of baseline (stim-A vs. stim-V, P < 0.001). Upon rewarming to
37C, all values returned to baseline. To investigate temperature
dependent effects on atrioventricular and endo-epicardial conduction,
regional differences were examined. No differences were found at 31C
but cooling to 17C reduced all conduction velocities (increased con-
duction times) when compared to baseline (P < 0.001). In particular,
endo–epi delay was 375% greater than control while V (ventricular side
of AV-node)-epi was 355% of baseline; both of these delays were pro-
longed more than A (atrial side of AV-node)-V (232%), and A-endo
(243%) delays (P < 0.01). Upon rewarming to 37C, endo-epi times did
not completely return to baseline values (119%) in contrast to all other
pathways involving atrial and ventricular conduction, which were fully re-
versed (Figures 2 and 3).
3.3 VF threshold
Cooling hearts to 31C decreased VF threshold compared to 37C
(30.5 ± 6.8 mA vs. 14.0 ± 2.2 mA, P < 0.05) indicating a more pro-
arrhythmic state. However, further cooling to 17C increased VF thresh-
old (64.2 ± 9.9 mA, P < 0.05) to a value higher than that seen at 37C.
During rewarming, a reversed sequence of VF threshold changes was
observed. The changes in VF threshold showed a high correlation coeffi-
cient (0.975) when compared with QR/QTc, which emerge as an ECG
marker of pro-arrhythmic activity. The electrical wavelength was calcu-
lated using the assumption that the APD90 approximates to the effective
refractory period, i.e. wavelength = CVl APD90; this index showed no
significant change throughout the experimental protocol (Supplemen-
tary material online, Figure S1). Direct measures of effective refractory
period were not made, and there remains the potential for
Figure 1 ECG characteristics and longitudinal vs. transverse conduction velocity measurements during cooling and rewarming (n = 14 hearts). (A)
Example ECG traces at 37C, 31C, and 17C. (B) Percentage change of ECG characteristics during cooling and rewarming compared to normothermic
baseline. (C) Absolute CV values represented along with percentage change. (D) Percentage change of CV characteristics during cooling and rewarming
compared to normothermic baseline. *Significant difference (P < 0.05) between temperatures (ECG) or significant differences between longitudinal and
transverse at same temperature (conduction velocity measurements), #Significant (P < 0.05) difference between PR/QT intervals and baseline (ECG), all
assessed by ANOVA and post hoc Tukey’s test.
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.hypothermia-induced changes of post-repolarization refractoriness to
independently alter electrical wavelength of the myocardium (Figure 3).
3.4 Whole heart action potential
characteristics
Measure of ventricular activation (TAct90 and TRise) were not changed
at 31C while repolarization characteristics (TRepol90 and APD90)
were prolonged by 124% (305.2 ± 6.3 ms vs. 380.2 ± 8.4 ms, P < 0.05)
and 136% (176.9 ± 4.2 ms vs. 241.0± 2.9 ms, P < 0.05), respectively.
Compared to baseline both APD90 and TAct90 were prolonged to the
same degree when hearts were cooled to 17C. APD90 showed a 242%
prolongation (135.5± 6.6 vs. 333.2 ± 7.8 ms, P < 0.05) and TAct90 was
prolonged by 246% (176.9 ± 4.2 vs. 428.2 ± 29.2 ms, P < 0.05). During
rewarming to 31C, TAct90 returned to baseline levels while APD90
was prolonged compared to baseline (176.9± 4.2 vs. 263.0 ± 5.2 ms,
P < 0.05). During rewarming to 37C, all parameters returned to base-
line levels. Dispersion of repolarization, measured as percent variation
from average APD90, was increased only after cooling to 17C (0.69% ±
0.25% vs. 3.49% ± 3.28%, P < 0.05) (Figures 4 and 5).
Epicardial CV (CVEpi) was measured with epicardial pacing on the RV/
LV border and analysing the subsequent spread of activation in the longi-
tudinal axis. Total intra-cardiac CV (CVTot) was calculated from TAct90
after right atrial pacing. CVEpi was reduced to 66% of baseline during
cooling to 31C (52.8 ± 7.3 vs. 35.2 ± 3.7 cm/s, P < 0.05), while CVTot
remained unchanged. After cooling to 17C, a CVEpi reduction to 37%
compared to baseline was observed (19.7± 3.7 cm/s, P < 0.05), with simi-
lar reduction of CVTot. On rewarming to 31C and 37C, CVEpi returned
to within values observed during cooling. At 31C, CVTot remained re-
duced (7.52 ± 0.41 vs. 6.57 ± 0.31 cm/s, P < 0.05) compared to baseline,
but returned to within baseline values at 37C.
3.5 Longitudinal vs. transverse conduction
3.5.1 In vitro
Cooling to 31C decreased CV in the longitudinal axis (CVl) by 32%
(76.3 ± 11.9 vs. 51.8± 10.1 cm/s) and by only 13.5% in the transverse
(CVt) (22.6± 1.4 vs. 19.5 ± 1.2 cm/s), decreasing the anisotropy ratio
(AR) from 3.4 to 2.7. At 17C, CVl decreased by 73.2% (76.3 ± 11.9 vs.
20.7± 4.2 cm/s) and CVt decreased by 52.3% (22.6 ± 1.4 vs.
10.5± 0.9 cm/s) (P < 0.01), giving an AR of 2. Rewarming to 31C in-
creased both CVl and CVt to values similar to that seen during cooling.
After rewarming to 37C, CV values were not different from pre-
cooling values (Figures 1 and 5).
3.5.2 In silico
To explore the role of the two major determinants of CV, propagation
along a myocardial fibre of fixed length was modelled computationally
(Figure 5). This model showed that reducing gap junctional (GJ) conduc-
tance by a quarter (e.g. from 2 to 0.5 mS) caused a 50% reduction in CVt
but only an 11% reduction in CVl. In contrast, reducing intracellular
Figure 2 Regional electrical activity (n = 6 hearts). (A) Placement of electrodes indicated by dashed lines (1 and 2) trans AV node, (3) RV septum, (4) LV
endocardium, (5) LV epicardium. (B) Example traces of recorded electrical activity. (C) Example traces indicating the peaks where recordings were mea-
sured. (D) Representative trace from one heart showing the changes in activation times during cooling.
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conductance to 25% of control reduced CVl by 34% whereas CVt is only
reduced by 5%.
3.5.3 Pharmacological manipulation in vitro
To assess the effects of altered CVl and CVt on pro-arrhythmic activity
during hypothermia, we used a subset group (n = 4) where the GJ uncou-
pler 1-heptanol (0.3 mM) was added to the perfusate for 5 min, following
which CV and VF threshold were measured. As previously reported,16
under normothermic conditions heptanol (0.3 mM) did not affect APD
significantly, did not affect the dispersion of repolarization, or the VF
threshold but caused an increase in conduction delay (Supplementary
material online, Table). Cooling to 31C slowed CVl to 64.4%
(81.3± 15.1 vs. 52.8± 11.0 cm/s) and CVt to 85.5% (14.2± 0.9 vs.
12.2± 0.7 cm/s) of baseline. The addition of heptanol further decreased
CVl to 55.6% (45.2± 8.5 cm/s) and CVt to 71.9% (10.2 ± 0.4 cm/s). VF
threshold was determined at 37C, 31C and at 31C following heptanol
perfusion. Cooling to 31C decreased VF threshold when compared to
37C (16.3± 3.1 vs. 35 ± 3.5 mA, P < 0.05). The addition of heptanol in
moderate hypothermia normalized VF threshold (16.3 ± 3.1 vs.
36.3± 4.3 mA, P < 0.05) to baseline (37C) values.
4. Discussion
We show that cooling to 31C does not change ventricular activation
but prolongs ventricular repolarization and is pro-arrhythmic. Cooling
to 17C causes parallel changes in ventricular activation and
repolarization and these changes are anti-arrhythmic. In silico modelling
suggests that low temperature sensitivity of GJ function relative to other
components determining CV is a potential explanation for the non-
linear effects on ventricular activation. These hypothermia-induced
changes in cardiac electrophysiology are clinically relevant.
Moderate hypothermia (<35C) is used for neuroprotection in coma-
tose survivors of cardiac arrest.17,18 Although recent studies question
whether avoiding hyperthermia provides the same effect,19–21 guidelines
still recommend cooling to between 32C and 36C.17 Accidental hypo-
thermia <30C is a severe condition, yet survival with good neurological
outcome is possible, even after rewarming from 13.7C.12 The neuro-
protective reduction in metabolic demands during severe hypothermia
is also utilized during surgical procedures.4,22 Nevertheless, treatment of
hypothermia-induced arrhythmias remains challenging6,7 and knowledge
of underlying mechanisms is of high clinical value.
4.1 Hypothermia and conduction through
the heart
The present study shows differential effects of myocardial conduction
within the moderate and severe ranges of hypothermia. At 31C, only a
mild delay in atrial and AV nodal conduction was present, while at 17C
conduction was significantly slower (Figure 2). This is consistent with hu-
man findings, where AV nodal conduction is slowed by direct cooling
with cold (4C) isotonic saline23 and in vivo studies, where 18.3C is a
critical temperature for the occurrence of AV-block.24 We show that
transmural ventricular conduction is relatively unchanged after cooling
to 31C, both through measurement of endo-epicardial conduction time
Figure 3 Percentage change of regional electrical activity during cooling and rewarming (n = 6 hearts) compared to normothermic baseline and VF thresh-
old (n = 7 hearts) during cooling and rewarming. (A) Change in time to measured electrical activity in individual areas of heart and (B) change in time to mea-
sured electrical activity between regions. (C) Mean VF threshold at all temperatures. (D) Individual values from each heart (dashed lines) showing cooling to
31C (n = 7) and to (E) 17C (n = 6). Solid line shows mean values. #Significant (P < 0.05) difference within temperature, *significant (P < 0.05) difference be-
tween temperatures, all assessed by ANOVA and post hoc Tukey’s test.
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..and CVt. This is in contrast to longitudinal conduction velocity which is
reduced by moderate hypothermia, shown by reduction in CVEpi and
CVl of 30–40%.
Panoramic optical mapping of hearts confirmed conduction times
from ECG and electrode-based measurements, showing unchanged ven-
tricular activation (TAct90, TRise) during moderate hypothermia while
repolarization (APD90 and TRepol90) is prolonged (Figure 4).
Therefore, moderate hypothermia slowed longitudinal cardiac conduc-
tion and repolarization, while ventricular/transmural activation and CVt
remained relatively unchanged, producing an acquired long-QT syn-
drome. Prolonged QT-interval is a common finding in hypothermic
patients.25 A meta-analysis shows increased risk of recurrent arrest in
therapeutic hypothermia,21 possibly due to QT prolongation. Further
cooling to 17C induces a significant delay of repolarization and global
activation (Tact90), including a significant increase in transmural conduc-
tion time and decreased CVt.
4.2 Ventricular fibrillation threshold during
hypothermia
VF threshold showed a different pattern of changes than conduction
times: cooling to 31C gave significant reduction in VF threshold (pro-
arrhythmic), while further cooling to 17C gave a more than two-fold in-
crease compared to at 37C (anti-arrhythmic). This finding implies that
electrophysiological changes at 31C provide a more stable substrate for
arrhythmias than at 17C. Indeed, it has been shown that cooling rabbit
hearts to 30C10 and in vivo cooling of dogs to 25C26 cause increased
vulnerability for VF. The current study is the first to demonstrate the bi-
phasic relationship in excitability of the ventricle, suggesting that moder-
ate hypothermia (31C) may be more vulnerable to induction of
arrhythmias than deep hypothermia (17C). Therapeutically, tempera-
tures <28–30C are thought to potentiate the occurrence of ventricular
arrhythmias. Yet 30C is the lower end of temperatures reported to be
used following cardiac arrest in the comatose patient.5
The underlying cause for VF threshold differences between moderate
and severe hypothermia remain unclear. Based on our data, it is possible
that the biphasic response to cooling is caused by changes in repolariza-
tion without effects on ventricular activation at 31C, contrasting with
17C where activation is prolonged in parallel with repolarization. The
QR-time of the ECG represents ventricular conduction from endocar-
dium to epicardium during sinus rhythm and is used as a marker of ven-
tricular activation.27 Since transmural conduction is mainly in the short
(i.e. transverse) axis and QR-time was unaltered at 31C, we examined
whether CVt and CVl are affected differentially in hypothermia.
Figure 4 Activation and repolarization characteristics during cooling and rewarming compared to normothermic baseline. Optical mapping data (n = 14
hearts) to show (A) time to 90% activation (TAct90) and (B) 90% action potential duration (APD90), displayed alongside (C) percentage values relative to
pre-hypothermic baseline. (D) Total cardiac (RA pacing) vs. epicardial CV (RV pacing). *Significant (P < 0.05) difference from baseline (37C), assessed by
ANOVA and post hoc Tukey’s test.
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4.3 CVl vs. CVt in hypothermia
Separate measurements of CV (Figure 1) show that moderate hypother-
mia had a differential effect with decreased longitudinal and unchanged
transverse conduction at 31C. Both decreased on further cooling to
17C. Computational modelling (Figure 5) showed that reducing GJ con-
ductance by a quarter caused a 50% reduction in CVt and 11% reduction
in CVl approximating the differential effects of moderate hypothermia. In
contrast, reducing intracellular conductance to 25% reduced CVl by 34%
and CVt by 5%. This modelling is in accordance with work by Jongsma
28
and suggests a hypothesis to explain the asymmetric changes in CVl and
CVt seen in hypothermia, namely that temperature-reduction to 31C
has higher impact on the electrophysiological components contributing
to intracellular resistance than those responsible for intercellular resis-
tance i.e. GJ function. The results from our in vitro experiment support
this pattern; CVt was relatively unchanged in moderate hypothermia,
while CVl was reduced by 32%. The aspects of cell electrophysiology
that contribute to the intracellular resistance component of the model
are uncertain. One potential determinant is sodium channel function; the
temperature sensitivity of the kinetics of this ion channel may contribute
to the temperature sensitivity of CV observed in the longitudinal axis.
Q10 values for sodium channel kinetics range from 2.5 to 3.029 while
Q10 values for gap junction resistance is considerably lower (1.4).30 This
is consistent with the hypothesis to explain the differential sensitivity of
CVl and CVt, but further work is required to provide further verification.
Recently, ephaptic transmission between cardiac cells has been sug-
gested as an alternative form of cell-to-cell coupling that could become
dominant under pathological conditions,16 the relative temperature sen-
sitivity of this mechanism to that of gap junctions is unknown and may
feature in the electrophysiological response to hypothermia.
The CV anisotropy ratio (AR) i.e. CVl/CVt, decreased in moderate hy-
pothermia because of reduced CVl (by 30%) and minimal change in
CVt. The hypothesis that the absence of significant change in CVt while
APD increased at 31C was key to the pro-arrhythmic state was sup-
ported by the response to heptanol, which decreased CVt with little ef-
fect on CVl at 31C and was able to increase VF threshold. These
manipulations were possible at 31C but not at 17C as both CVl and
CVt decreased to very low values in severe hypothermia. Therefore, AR
changes accompany hypothermia, but absolute CVs rather than relative
CVs appear important in determining pro-arrhythmic state.
4.4 Mechanisms of arrhythmias in
hypothermia
It is known that ventricular arrhythmias can arise from disruptions in the
normal sequence of activation and repolarization.31 The primary change
in ventricular electrophysiology at 31C is prolongation of the APD and
increased heterogeneity of ventricular repolarization, both of which are
considered pro-arrhythmic changes. Interestingly, in humans the same
relationships are apparent from a recent systematic review of clinical
data.7 Cooling further from 31C to 17C caused prolongation of APD
and QT, but the accompanying increase in QRS and decrease in CVt is
associated with an increase in VF threshold to normothermic values.
This suggests that prolonged and heterogeneous repolarization is only
Figure 5 Effect of gap junction uncoupler heptanol (0.3 mM) in moderate hypothermia and computational modelling of longitudinal and transverse con-
duction. (n = 9 hearts): (A) Change in longitudinal vs. transverse conduction at 31C (relative to 37C), with and without addition of heptanol and (B) VF
threshold at 31C and following the perfusion of heptanol. *Significant (P < 0.05) difference from baseline (37C), assessed by ANOVA and post hoc Tukey’s
test. (C) Schematic representation of an idealized cuboid cell of length lcell, width dcell, showing resistance to current flow along and transverse to the cell’s
length where Rcl is the cytoplasmic resistance along the cell, Rct is the cytoplasmic resistance transverse to the cell, and Rj is the resistance of the gap junc-
tion. (D) Variation in CV as gap junction conductivity is varied and (E) variation in CV as intracellular conductivity is varied.
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pro-arrhythmic in presence of normal transmural conduction times.
A corollary of this proposition is that slowing transmural CV and conse-
quently prolonging ventricular activation, would be anti-arrhythmic.
Osborn waves (J-waves) are often associated with ECG recordings
from hypothermic patients.7 We observed J-waves in approximately
25% of hearts (Supplementary material online, Figure S2). Occurrence of
J-waves varies substantially between clinical studies. Darocha et al.32
found J-waves in only 3 of 19 severely hypothermic patients (<26.2C),
while in South Korea, VF only occurred in 1.7% of J-wave patients.33 This
and other literature reinforce the poor association of hypothermia with
occurrence of J-waves and the poor association of J-waves with the inci-
dence of hypothermia-induced ventricular arrhythmias.7
4.5 Pharmacological lowering of CV raises
VF threshold during hypothermia, a
potential therapeutic intervention
To test the hypothesis that hypothermia-induced increase in APD with
simultaneous decrease in CVl but maintained CVt, was a key require-
ment for the pro-arrhythmic state, VF threshold was examined at mod-
erate hypothermia (31C) before and after pharmacological reduction in
CVt. Computational modelling suggested that selective reduction in CVt
over CVl was a consequence of reduced GJ conductance, a feature also
predicted in other modelling studies.28 Accordingly, we tested the GJ un-
coupler heptanol (0.3 mM). This dose was previously shown to reduce
ventricular CV while minimally affecting other aspects of cardiac electro-
physiology.34 Under normothermic conditions, 0.3 mM heptanol had no
effect on VF threshold, APD, and APD dispersion (see Supplementary
material online, Table). The GJ-selective action of 0.3 mM heptanol was
supported by the relatively greater reduction of CVt than CVl, (Figure 5).
CVt was reduced to approximately the same relative extent as other
electrophysiological parameters at 31C while minimally affecting APD
and CVl. This intervention had a marked anti-arrhythmic effect, evi-
denced by a significant increase in VF threshold. These findings support
the hypothesis that the low temperature sensitivity of gap-junction con-
ductance relative to other components of cardiac electrophysiology is
an important pro-arrhythmic factor during moderate hypothermia.
Using heptanol as a model drug, we therefore suggest that modulation of
GJ function is a potential therapeutic target to protect hypothermic
patients from arrhythmias. This necessitates further studies, testing the
wide range of known drugs that uncouple cardiovascular gap junctions,35
with the aim to improve the clinical treatment of hypothermic patients.
5. Conclusions
Cooling to moderate hypothermia levels (31C) alters ventricular repo-
larization but transmural conduction time remained relatively
unchanged. This combination of effects appears to be pro-arrhythmic.
Further cooling to severe hypothermia levels (17C) causes parallel
changes in transmural conduction and repolarization which conversely
appears anti-arrhythmic. These non-uniform changes in conduction and
APD are reflected in QR and QT-intervals of the ECG and suggests QR/
QTc as a potential biomarker for pro-arrhythmic state during hypother-
mia; where a relative prolongation of the corrected QT-interval com-
pared to QR-interval, as observed in moderate hypothermia (31C),
indicates increased risk for ventricular arrhythmia. This is applicable to
both therapeutic interventions and in accidental hypothermia patients.
Further, as demonstrated with a computational model, the insensitivity
of CVt relative to CVl in hypothermia is consistent with a low
temperature sensitivity of GJs relative to other aspects of cardiac elec-
trophysiology. Considering these findings, a potential treatment strategy
to prevent ventricular arrhythmias in moderate hypothermia is reduc-
tion of GJ conduction, a concept supported by the anti-arrhythmic
effects of heptanol at 31C. Current treatment-guidelines for accidental
hypothermia provide little evidence-based information for anti-
arrhythmic treatment, a condition associated with a high mortality rate.
Therefore, our findings offer a promising foundation for detecting ar-
rhythmia susceptibility and development of treatment strategies in hypo-
thermic patients.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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Translational perspective
Accidental hypothermia is associated with a high mortality rate caused by cardiovascular complications; mainly cardiac arrest. Guidelines for how to
treat patients with accidental hypothermia do however lack advice on anti-arrhythmic treatment. In the present article, we suggest a potential bio-
marker for pro-arrhythmic state during hypothermia and show that moderate hypothermia is more pro-arrhythmic than severe hypothermia.
Further, we present a potential treatment strategy to prevent ventricular arrhythmias in moderate hypothermia through reduction of gap junction
conduction. Therefore, our findings offer a promising foundation for detecting arrhythmia susceptibility and development of treatment strategies in
hypothermic patients.
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